Low float biotech mania, huge moves today

Here are our top 3 trade ideas today – these setups look primed! Good day, 360 – Here are our top 3 trade ideas today – these setups look primed! And check out our NEWEST addition at the bottom, Market News. Let us know what you think! APVO - Trades over 60% high in pre-market after announcing 100% Clinical Benefit rate achieved in Phase 1b trial in treatment of patients with Acute Myeloid Leukemia HTGM - Trades over 190% higher after trading 45 million shares on Friday SMMT - Still in play, after closing 4th day in a row higher [Jeff Bishop Opens Up Bullseye Trades to All Today Only!]( Bullseye Trades will be LIVE at 11am EST today in the [360 Wall Street Chat Room]( for all – not just members. Jeff will break down his Bullseye trade for this week…and also talk about last week’s 100% winner – be there!!! The Bullseye Trade is Jeff’s best trade idea for the week subscribed to by thousands and thousands of members. >>Get your access at 0 cost at 11am today [HERE](!<< APVO - Trades over 60% high in pre-market after announcing 100% Clinical Benefit rate achieved in Phase 1b trial in treatment of patients Low float small cap biotechs have been in play over the past few days after SMMT made its big run. After releasing this news on Sunday, APVO was up over 100% from 4am this morning running from $4 to $8 in the first 45 minutes of the pre-market. It has pulled back a little since then, but there is sure to be activity in this one today. The stock only has a float of 5.04 million shares according to Finviz and closed yesterday with a market cap of $17.71 million on Friday. The $7 level was resistance in the pre-market with a seller at this level. This looks like an important pivot point for today. Above it, the pre-market high of $8.20 is the first major hurdle. A hold above that the next targets would be $9 prior resistance, the psychologically important $10 and then $11. $14 was a major support/resistance level from last year. Below $7 there was some buying at $6.50 in the pre-market, with a more significant support at $5.40 which is a major level. Then the $4.50 area is in play below that, where the big move in the pre-market took off from. HTGM - Trades over 190% higher after trading 45 million shares on Friday HTGM was up over 190% in pre-market trade. As implied earlier, it appears some mania is returning to small cap biotechs after they have sold off heavily for the better part of the year. HTGM announced on Friday that it would hold a webinar on Tuesday December 13 (Tomorrow) and would present results. It traded more than 5 times its 8.48 million share float according to Finviz and is on pace to trade many times that today. The pre-market high is $1.83 and that is the first major target for the bulls. Below that, there is potential support around $1.30-$1.38, then $1.18 and then the psychologically important $1. Yesterday’s high was $0.75. Above the pre-market high, $2 comes into play with a major resistance level at $2.08. Above that the next major levels are $3 and $3.20. Jeff Williams was trading HTGM all day Friday live in the 360 chat room – check it out! SMMT - Still in play, after closing 4th day in a row higher SMMT perhaps the stock that got this low float biotech party started last week continues to hold higher, giving short sellers no break. The stock closed near its highs if looking at the weekly chart, so perhaps there is still more juice left in this one. Once the buyers walk, there could be a big unwind lower not in just SMMT but all these related low floats. If trading one, it would be wise to keep an eye on all of them for any hints to further price action. Last week’s high was $4.50 so that is an important level to watch. A hold above $4.50 could see shorts tap out fast and a measured move (since this started at $0.80) puts $8.20 in play this week. There is also a gap to fill at $5. The $4.12 area was also resistance on Thursday and Friday. Below that there is potential support at $3.50, $3, $2.50, $2 and $1.50 is not out of the question below that if buyers walk. Monday’s Economic Calendar Treasury Statement 2:00pm ET S&P 500 posts worst weekly showing since late Sept. ahead of final Fed meet of the year Twitter To Relaunch Subscription Service Twitter Blue On Monday MUSK SAYS “YES” WHEN ASKED IF ITS TRUE TWITTER IS SET TO INCREASE CHARACTERS FROM 280 TO 4000 BA Air India Finalizing Order For A Total Of Up To 500 Jets From Airbus And Boeing - Sources Air India Order to Include Around 100 Wide-Body Jets Including Airbus A350 And Boeing 787 and 777. AMGN HZNP Amgen In Advanced Talks To BUY Horizon Therapeutics, Sources Say -- WSJ takeover of Rare-Disease Drugmaker Could Be Finalized By Monday, Sources Say -- WSJ deal Would Likely Value Horizon At Well Over $20 Billion – WSJ US Prosecutors Consider Charging Binance and Executives for Possible Money Laundering, Sanctions Violations – RTRS CHINA WARNED TO ACCELERATE APPROVAL OF UPDATED JABS TO TACKLE COVID ‘TSUNAMI’ – FTChinese Premier Li Says China Will Further Open Up Domestic Market IBIO: Closing of $3.5 Million Underwritten Public Offering ADMA: Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares TNXP: Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventive Humanized Anti-SARS-CoV-2 Monoclonal Antibodies from Curia Global, Inc. APVO 100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML) CLVS Down Premarket After Co Files for Bankruptcy Protection AAPL Hon Hai Expects to Resume Normal Iphone Production in Dec: Citi ARQT Arcutis Announces Positive Topline Results from Second Atopic Dermatitis Pivotal Phase 3 Trial of Roflumilast Cream in Adults and Children Aged 6 and Older META Facebook knew Instagram was pushing girls to dangerous content: internal document - 60 Minutes BDTX: Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company To Your Success! 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of []( or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. [RagingBull.com](, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with [RagingBull.com](, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, [RagingBull.com](, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 lee, NH 03861, United States [Publish on beehiiv](